Gerry A. Quinn
Peer Reviewed Paper Calls for Stronger Safety Standards for Modified mRNA Vaccines
COVID-19 experience raises questions about manufacturing, biological persistence and long-term safety OCALA, Fla., Oct. 26, 2026 — Gerry A. Quinn,…
Company newsroom
1 releases
COVID-19 experience raises questions about manufacturing, biological persistence and long-term safety OCALA, Fla., Oct. 26, 2026 — Gerry A. Quinn,…